Alkermes (ALKS) P/E ratio

P/E ratio · fiscal 2025
19.6×

The P/E ratio of Alkermes (ALKS) was 19.6× at the end of fiscal 2025 (December 31, 2025). That is 47.6% higher than the 13.3× of fiscal 2024. Figures as of 18 Nov 2026, 09:31 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/E ratio, fiscal 2025
19.6×
Change on fiscal 2024
+47.6%
Highest on record
290.4×fiscal 2013
Lowest on record
13.2×fiscal 2023
Fiscal years on record
52013–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Alkermes P/E ratio, in more detail

Across the 5 fiscal year-ends on record (2013–2025), the highest was 290.4× in fiscal 2013 and the lowest 13.2× in fiscal 2023.

History · 5 fiscal years

P/E ratio at each fiscal year-end

Alkermes P/E ratio, year by year

Alkermes (ALKS) P/E ratio by fiscal year
Fiscal yearP/E ratioChangeYear endedShare price at year-endDiluted EPS
202519.6× 47.6% up$27.98$1.43
202413.3× 0.3% up$28.76$2.17
202313.2×—$27.74$2.10
2022——$26.13-$0.97
2021——$23.26-$0.29
2020——$19.95-$0.70
2019——$20.40—
2018——$29.51—
2017——$54.73—
2016——$55.58—
2015——$79.38-$1.52
2014——$58.56-$0.21
2013290.4×—$40.66$0.14
2013131.7×—$23.70$0.18
2012——$18.55-$0.99
2011——$12.95-$0.48
2010——$12.97-$0.42

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

How to read it

It is the number of years of current profit the price pays for — a high figure means investors expect growth, and it is best judged against the company's own history.

P/E ratio at health care companies of similar size

P/E ratio of Alkermes and comparable companies
CompanyP/E ratio
PACS Group PACS27.6×
Kiniksa Pharmaceuticals International KNSA72.1×

Price over the last twelve months' earnings per share, as the market data feed reports it.

More on ALKS

Alkermes, figure by figure

Alkermes (ALKS) overview: price, valuation and scorecardAll health care companies by market value

Alkermes P/E ratio: questions and answers

What is Alkermes's P/E ratio?

The P/E ratio of Alkermes (ALKS) was 19.6× at the end of fiscal 2025 (December 31, 2025). That is 47.6% higher than the 13.3× of fiscal 2024.

What are the highest and lowest P/E ratio figures on record for Alkermes?

Across the 5 fiscal year-ends on record (2013–2025), the highest was 290.4× in fiscal 2013 and the lowest 13.2× in fiscal 2023.

How is Alkermes's P/E ratio calculated?

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E. For Alkermes it is on record here for 5 fiscal years, 2013 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Alkermes (ALKS) P/E ratio”, data as of 18 November 2026. https://funkfolio.com/stock/ALKS/pe-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.